← Back to search

LEIDOS BIOMEDICAL RESEARCH INC

FREDERICK, MD, 21702

UnclaimedClaim this profile (free)

Prime contracting experience

Showing the 50 most recent of 238 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Prime
Department of Health and Human Services
National Institutes of Health
NCI OPERATIONAL TASK ORDER, FY26-FY2775N91019D00024USAspending$825,985,691Sep 30, 2026Aug 31, 2025 – Aug 30, 2027
Prime
Department of Health and Human Services
National Institutes of Health
FUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYS75N91019D00024USAspending$72,167,416Sep 29, 2026Sep 29, 2026 – Sep 28, 2031
Prime
Department of Health and Human Services
National Institutes of Health
PALM004: AN OBSERVATIONAL STUDY OF THE NATURAL HISTORY OF BUNDIBUGYO VIRUS DISEASE75N91019D00024USAspending$11,725,031Sep 25, 2026Sep 25, 2026 – Sep 24, 2029
Prime
Department of Health and Human Services
National Institutes of Health
THE NIAID DIR FY26-27 OPERATIONAL TASK ORDER75N91019D00024USAspending$17,766,274Sep 25, 2026Aug 31, 2025 – Aug 30, 2027
Prime
Department of Health and Human Services
National Institutes of Health
MANUFACTURING PROCESS DEVELOPMENT OF 4-HB75N91019D00024USAspending$1,270,276Sep 25, 2026Sep 15, 2025 – Sep 14, 2030
Prime
Department of Health and Human Services
National Institutes of Health
NIAID DCR FY26-27 OPERATIONAL TASK ORDER75N91019D00024USAspending$137,656,019Sep 25, 2026Aug 31, 2025 – Aug 30, 2026
Prime
Department of Health and Human Services
National Institutes of Health
NIAID / CHILDRENS NATIONAL MEDICAL CENTER JOINT CLINICAL RESEARCH PROGRAM (JCRP) IMMUNOLOGIC AND INFECTIOUS DISEASES CLINICAL RESEARCH75N91019D00024USAspending$10,001,104Sep 25, 2026Sep 2, 2022 – Sep 1, 2027
Prime
Department of Health and Human Services
National Institutes of Health
CLINICAL MATERIAL TECHNOLOGY DEVELOPMENT AND PILOT MANUFACTURING75N91019D00024USAspending$17,712,309Sep 24, 2026Sep 24, 2026 – Sep 23, 2031
Prime
Department of Health and Human Services
National Institutes of Health
NCATS-DPI-22-0101 - CREATION OF AN OPEN-SOURCE PROCESS TO MANUFACTURE AAV VECTOR-BASED GENE THERAPY CANDIDATES FOR NON-COMMERCIAL CLINICAL STUDIES75N91019D00024USAspending$13,973,744Sep 23, 2026Sep 12, 2022 – Sep 11, 2027
Prime
Department of Health and Human Services
National Institutes of Health
INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES75N91019D00024USAspending$1,683,296Sep 23, 2026Sep 28, 2026 – Sep 27, 2031
Prime
Department of Health and Human Services
National Institutes of Health
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS75N91019D00024USAspending$30,072,496Sep 23, 2026Sep 23, 2019 – Mar 31, 2031
Prime
Department of Health and Human Services
National Institutes of Health
FFRDC MOONSHOT PORTFOLIO TASK ORDER75N91019D00024USAspending$33,139,792Sep 22, 2026Aug 31, 2019 – Sep 30, 2027
Prime
Department of Health and Human Services
National Institutes of Health
ENABLING NCI CLINICAL & RESEARCH DATA SHARING75N91019D00024USAspending$98,565,259Sep 22, 2026Aug 31, 2021 – Feb 28, 2028
Prime
Department of Health and Human Services
National Institutes of Health
HHSN261201500003I; HHSN26100071; 400.021.0071.0001; NCI CBIIT; APPROPRIATED; EXPAND DATA COMMONS; 09/14/18-09/13/23HHSN261201500003IUSAspending$72,263,032Sep 17, 2026Sep 11, 2018 – Aug 31, 2029
Prime
Department of Health and Human Services
National Institutes of Health
NCI-ARCDCTD-26-0055 - CPTAC BIOSPECIMEN ACQUISITION, PROCESSING, AND DISTRIBUTION75N91019D00024USAspending$4,538,288Sep 15, 2026Sep 21, 2026 – Sep 20, 2027
Prime
Department of Health and Human Services
National Institutes of Health
DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS75N91019D00024USAspending$1,649,757Sep 14, 2026Sep 15, 2023 – Sep 14, 2026
Prime
Department of Health and Human Services
National Institutes of Health
INTEGRATED DMPK AND TOXICOLOGY PROFILING OF NCATS/TDB MEDICINAL CHEMISTRY LEAD CANDIDATES75N91019D00024USAspending$1,088,780Sep 14, 2026Sep 21, 2026 – Sep 20, 2029
Prime
Department of Health and Human Services
National Institutes of Health
CORE SUPPORT FOR THE IMMUNE CELL NETWORK75N91019D00024USAspending$26,946,544Sep 14, 2026Sep 16, 2021 – Dec 31, 2027
Prime
Department of Health and Human Services
National Institutes of Health
HHSN261201500003I; HHSN26100080; 400.001.0080.0001; NCI OD-FREDERICK; APPROPRIATED; 125073 BLDG. 560, ROOF EXHAUST STACKS; 9/24/2018 - 3/18/2022HHSN261201500003IUSAspending$9,985,093Sep 11, 2026Sep 22, 2018 – Dec 31, 2026
Prime
Department of Health and Human Services
National Institutes of Health
IMPLEMENTATION AND CHARACTERIZATION OF IPSC-DERIVED CELL AND ORGANOID MODELS FOR INTEGRATION INTO NEW APPROACH METHODOLOGIES (NAMS)75N91019D00024USAspending$1,323,885Sep 10, 2026Sep 21, 2026 – Sep 20, 2031
Prime
Department of Health and Human Services
National Institutes of Health
NIAID COVID-19 ACTIV375N91019D00024USAspending$159,121,570Sep 9, 2026Sep 2, 2020 – Feb 28, 2027
Prime
Department of Health and Human Services
National Institutes of Health
HNGR(310)FC GMP3 CAMPAIGN AND OCTET METHOD DEVELOPMENT75N91019D00024USAspending$9,231,560Sep 8, 2026Sep 16, 2019 – Sep 2, 2027
Prime
Department of Health and Human Services
National Institutes of Health
126889 B571 REPLACE CHILLER #375N91019D00024USAspending$1,291,828Sep 8, 2026Sep 8, 2026 – May 3, 2028
Prime
Department of Health and Human Services
National Institutes of Health
FY26 FFRDC LEASES75N91019D00024USAspending$28,530,382Sep 4, 2026Aug 31, 2025 – Aug 30, 2026
Prime
Department of Health and Human Services
National Institutes of Health
FY26 125346 - B539 STORM DRAIN REPLACEMENT75N91019D00024USAspending$1,064,983Sep 4, 2026Sep 8, 2026 – Jun 30, 2028
Prime
Department of Health and Human Services
National Institutes of Health
126297 CAMPUS EVALUATE & REPLACE DEFICIENT ALTERNATING TREAD AND SHIP STAIRS75N91019D00024USAspending$806,968Sep 3, 2026Sep 15, 2026 – Aug 23, 2028
Prime
Department of Health and Human Services
National Institutes of Health
CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)75N91019D00024USAspending$79,896,408Sep 3, 2026Feb 10, 2021 – Oct 31, 2026
Prime
Department of Health and Human Services
National Institutes of Health
MD NET75N91019D00024USAspending$181,379,395Sep 3, 2026Sep 26, 2019 – Oct 31, 2029
Prime
Department of Health and Human Services
National Institutes of Health
126797 CAMPUS REPLACE BSCS75N91019D00024USAspending$1,912,753Sep 3, 2026Sep 30, 2026 – Oct 25, 2028
Prime
Department of Health and Human Services
National Institutes of Health
NIAID VRC PRE-CLINICAL ASSESSMENT75N91019D00024USAspending$16,097,583Aug 31, 2026Jun 17, 2024 – Aug 31, 2031
Prime
Department of Health and Human Services
National Institutes of Health
126729 ROOM 524 D, E, F75N91019D00024USAspending$1,102,374Aug 28, 2026Sep 8, 2026 – Oct 19, 2028
Prime
Department of Health and Human Services
National Institutes of Health
NIAID VRC FY26-27 OPERATIONAL TASK ORDER75N91019D00024USAspending$87,806,507Aug 27, 2026Aug 31, 2025 – Aug 30, 2027
Prime
Department of Health and Human Services
National Institutes of Health
126869 B539 & 560 - ROOF REPLACEMENTS75N91019D00024USAspending$1,511,990Aug 27, 2026Sep 9, 2026 – May 5, 2028
Prime
Department of Health and Human Services
National Institutes of Health
FFRDC DRUG PRODUCT FORMULATION, MANUFACTURE, AND STABILITY STUDIES OF BETHANECHOL CHLORIDE FOR PHASE I CLINICAL TRIALS75N91019D00024USAspending$1,644,574Aug 26, 2026Sep 21, 2026 – Sep 20, 2031
Prime
Department of Health and Human Services
National Institutes of Health
IGF::OT::IGF RESEARCH, DEVELOPMENT, PRODUCTION AND SUPPORT FOR CLINICAL TRIALS ? BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES (BNMABS)HHSN261201500003IUSAspending$27,524,748Aug 25, 2026Sep 19, 2016 – Sep 18, 2021
Prime
Department of Health and Human Services
National Institutes of Health
CHARACTERIZATION OF MPOX75N91019D00024USAspending$5,583,900Aug 24, 2026Sep 29, 2025 – Mar 28, 2027
Prime
Department of Health and Human Services
National Institutes of Health
FFRDC PTH-1A DRUG PRODUCT FOR PEDIATRIC DOSING75N91019D00024USAspending$559,073Aug 24, 2026Sep 21, 2026 – Sep 20, 2030
Prime
Department of Health and Human Services
National Institutes of Health
126864 MULTI BUILDING DRY CHEM FIRE SUPPRESSION SYSTEM75N91019D00024USAspending$880,989Aug 24, 2026Sep 2, 2026 – Aug 21, 2028
Prime
Department of Health and Human Services
National Institutes of Health
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA75N91019D00024USAspending$9,492,218Aug 21, 2026Jun 30, 2020 – Jun 12, 2026
Prime
Department of Health and Human Services
National Institutes of Health
ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT75N91019D00024USAspending$21,659,702Aug 21, 2026Sep 16, 2021 – Aug 21, 2029
Prime
Department of Health and Human Services
National Institutes of Health
FY25 FACILITIES TO E - 126663 B539 MISC SAFETY UPGRADES75N91019D00024USAspending$1,676,963Aug 20, 2026Sep 4, 2025 – Jun 30, 2028
Prime
Department of Health and Human Services
National Institutes of Health
WEDGEWOOD EXPANSION DESIGN SUITES M & N75N91019D00024USAspending$7,763,273Aug 19, 2026Sep 20, 2021 – Jan 26, 2027
Prime
Department of Health and Human Services
National Institutes of Health
FY25 FACILITIES TASK ORDER A - REPLACE WOOD STREET STEAM & CONDENSATE PIPING75N91019D00024USAspending$3,035,294Aug 12, 2026May 7, 2025 – Sep 17, 2027
Prime
Department of Health and Human Services
National Institutes of Health
TAS::75 0849::TAS OPER OF GOVT R&D GOCO FACILITIES—$4,811,722,791Aug 7, 2026Sep 26, 2008 – Sep 6, 2024
Prime
Department of Health and Human Services
National Institutes of Health
DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES75N91019D00024USAspending$4,557,516Aug 3, 2026Sep 15, 2025 – Sep 14, 2030
Prime
Department of Health and Human Services
National Institutes of Health
126827 BUILDING 1023 ROOMS 8 AND 9 BSC REPLACEMENT75N91019D00024USAspending$652,353Jul 30, 2026Jul 30, 2026 – Nov 15, 2027
Prime
Department of Health and Human Services
National Institutes of Health
FY25 FACILITIES TO G CONSTRUCTION OF BMP STRUCTURES FOR MDE STORM-WATER COMPLIANCE75N91019D00024USAspending$2,670,576Jul 24, 2026Aug 21, 2025 – Sep 1, 2027
Prime
Department of Health and Human Services
National Institutes of Health
NIAID-VRC-MRNA VACCINE CAPABILITY ESTABLISHMENT75N91019D00024USAspending$25,098,522Jul 22, 2026Sep 2, 2022 – Jun 17, 2030
Prime
Department of Health and Human Services
National Institutes of Health
THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAIDS GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATES TO SUPPORT FOR ADVANCED DEVELOPMENT.75N91019D00024USAspending$173,281,267Jul 22, 2026Jun 1, 2023 – May 31, 2029
Prime
Department of Health and Human Services
National Institutes of Health
MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE75N91019D00024USAspending$730,402Jul 20, 2026Sep 15, 2025 – Sep 14, 2030

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

  • Department of Health and Human ServicesGov-sourced

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

LEIDOS BIOMEDICAL RESEARCH INC – Frederick, MD | UEI HV8BH9BPG8Y9 | FedSub